You are here

Martin Shkreli

Supreme Court turns down Martin Shkreli's latest appeal, leaving 'pharma bro' to 7-year sentence

Supreme Court turns down Martin Shkreli's latest appeal, leaving 'pharma bro' to 7-year sentence

Endpoints

Flag link:

Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma

Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma

BioSpace

Elizabeth Holmes

Flag link:

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails

Xconomy

fosmetpantotenate

Flag link:

Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes

Retrophin paid Martin Shkreli 'undisclosed sum' to settle yearslong legal disputes

Endpoints

Flag link:

Fraud conviction of ‘pharma bro’ Martin Shkreli upheld by federal appeals court

Fraud conviction of ‘pharma bro’ Martin Shkreli upheld by federal appeals court

CNBC

Flag link:

After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin

After years of claims and accusations, fraudster Martin Shkreli settles up with Retrophin

Endpoints

Flag link:

Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues

Shkreli settles into his new prison digs in Pennsylvania with a $30M+ lawsuit against former Retrophin colleagues

Endpoints

Flag link:

Martin Shkreli gets a transfer to Brooklyn federal prison in wake of his latest rule-breaking escapades behind bars

Martin Shkreli gets a transfer to Brooklyn federal prison in wake of his latest rule-breaking escapades behind bars

Endpoints

Flag link:

What's Going on With Martin Shkreli Lately?

What's Going on With Martin Shkreli Lately?

BioSpace

Flag link:

Prison Bureau to Investigate Shkreli’s Alleged Use of a Contraband Phone

Prison Bureau to Investigate Shkreli’s Alleged Use of a Contraband Phone

BioSpace

Flag link:

Made for TV: Shkreli running his drug company from prison cell, WSJ says

Made for TV: Shkreli running his drug company from prison cell, WSJ says

Fierce Pharma

Flag link:

What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs

What do Martin Shkreli, Gilead and Takeda have in common? They all figure prominently in the new top-20 list of the world’s most expensive drugs

Endpoints

Gilead Sciences

Flag link:

Another Shkreli-like drug price controversy? Leadiant finds itself in the spotlight after 500-fold price hike — FT

Another Shkreli-like drug price controversy? Leadiant finds itself in the spotlight after 500-fold price hike — FT

Endpoints

Leadiant Biosciences

Flag link:

Ex-lawyer of pharma executive Shkreli gets 18 months prison for fraud scheme

Ex-lawyer of pharma executive Shkreli gets 18 months prison for fraud scheme

Reuters

Flag link:

Three years after steep price hike, Martin Shkreli’s drug company is losing money, documents show

Three years after steep price hike, Martin Shkreli’s drug company is losing money, documents show

Stat

Vyera Pharmaceuticals

Turing Pharmaceuticals

Flag link:

Is Martin Shkreli blogging from prison?

Is Martin Shkreli blogging from prison?

Endpoints

Flag link:

Shkreli is in prison, but Daraprim’s price is still high

Shkreli is in prison, but Daraprim’s price is still high

Endpoints

Turing Pharmaceuitcals

Flag link:

No leniency for Shkreli: Bad-boy pharma executive gets 7 years in prison for fraud

No leniency for Shkreli: Bad-boy pharma executive gets 7 years in prison for fraud

Fierce Pharma

Flag link:

The Martin Shkreli saga ends today, but the issue he raised on drug pricing seems immortal

The Martin Shkreli saga ends today, but the issue he raised on drug pricing seems immortal

Endpoints

Flag link:

Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus

Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus

Endpoints

clinical trials

Flag link:

Pages